Novo Nordisk's dosing in CagriSema obesity drug trial puzzles investors - Reuters

Reuters | Dec. 20, 2024, 12:26 p.m. | Original
Novo Nordisk's dosing in CagriSema obesity drug trial puzzles investors Reuters
Polish broadcaster TVN owners begin sale process, sources say - Reuters.com Upstream jobs in Texas oil slipped in Nov, industry group says - Reuters.com